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Diesel exhaust particulate induces pulmonary and
systemic inflammation in rats without impairing
endothelial function ex vivo or in vivo
Sarah Robertson1,3*, Gillian A Gray1, Rodger Duffin2, Steven G McLean1, Catherine A Shaw1, Patrick WF Hadoke1,
David E Newby1 and Mark R Miller1
Abstract
Background: Inhalation of diesel exhaust impairs vascular function in man, by a mechanism that has yet to be
fully established. We hypothesised that pulmonary exposure to diesel exhaust particles (DEP) would cause
endothelial dysfunction in rats as a consequence of pulmonary and systemic inflammation.
Methods: Wistar rats were exposed to DEP (0.5 mg) or saline vehicle by intratracheal instillation and hind-limb
blood flow, blood pressure and heart rate were monitored in situ 6 or 24 h after exposure. Vascular function was
tested by administration of the endothelium-dependent vasodilator acetylcholine (ACh) and the endothelium-
independent vasodilator sodium nitroprusside (SNP) in vivo and ex vivo in isolated rings of thoracic aorta, femoral
and mesenteric artery from DEP exposed rats. Bronchoalveolar lavage fluid (BALF) and blood plasma were collected
to assess pulmonary (cell differentials, protein levels & interleukin-6 (IL-6)) and systemic (IL-6), tumour necrosis
factor alpha (TNFa) and C-reactive protein (CRP)) inflammation, respectively.
Results: DEP instillation increased cell counts, total protein and IL-6 in BALF 6 h after exposure, while levels of IL-6
and TNFa were only raised in blood 24 h after DEP exposure. DEP had no effect on the increased hind-limb blood
flow induced by ACh in vivo at 6 or 24 h. However, responses to SNP were impaired at both time points. In
contrast, ex vivo responses to ACh and SNP were unaltered in arteries isolated from rats exposed to DEP.
Conclusions: Exposure of rats to DEP induces both pulmonary and systemic inflammation, but does not modify
endothelium-dependent vasodilatation. Other mechanisms in vivo limit dilator responses to SNP and these require
further investigation.
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Background and objectives
Exposure to air pollution has been associated with
increased cardiovascular mortality and morbidity [1-3].
These associations are strongest for the particulate matter
(PM) in air pollution, and the World Health Organisation
has estimated that airborne particles are responsible for
half a million premature deaths each year [4]. Ultrafine
particles (or nanoparticles) are of specific concern because
their small size allows them to penetrate deep into the
respiratory tract [5] and also engenders them with a large
reactive surface area. Exhaust from diesel engines is espe-
cially rich in nanoparticles and, therefore, may contribute
greatly to the health effects of PM in urban environments
[6,7].
The mechanism(s) by which inhaled PM alters cardiovas-
cular function has not been established. We have shown
that controlled exposure to diesel exhaust impairs endothe-
lial vasomotor function in healthy volunteers [8-10] and in
patients with stable coronary heart disease [11]. The vascu-
lar impairment observed appears to be mediated by the
particulate component of the exhaust rather than the gas-
eous co-pollutants [7,10]. Furthermore, ex vivo exposure of
blood vessels to diesel exhaust particles (DEP) inhibits
nitric oxide (NO)-mediated vasodilatation via generation of
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superoxide free radicals [12]. Thus, DEP can directly alter
endothelial cell function but this assumes that a consider-
able number of the particles are able to translocate from
the lung to the circulation. While studies have demon-
strated that translocation of nanoparticles is feasible
[13-15] there remains considerable uncertainty over
whether this mechanism underlies the health effects of
combustion-derived nanoparticles [16-18]. An alternative
suggestion is that inflammation induced by PM in the lung
may spill-over into the systemic circulation, causing indir-
ect cardiovascular changes [19]. Several different types of
particulate have been shown to induce pulmonary inflam-
mation [18,20], but the occurrence and potential role of
systemic inflammation following pulmonary exposure to
particulates is often inconsistent [8,21,22]. We hypothesise
that instillation of DEP will cause endothelial dysfunction
in rats as a consequence of pulmonary and systemic
inflammation. Analysis of arteries isolated from PM-
exposed animals has generally shown little evidence of dys-
function. However, this may be due to limitations of ex
vivo analyses, which remove the vessel from neurohu-
moural control in vivo. Therefore, we addressed our
hypothesis by measuring arterial function both in vivo (in
the hind-limb resistance bed) and ex vivo in isolated con-
duit (aorta, femoral) and resistance (mesenteric) arteries
following intra-tracheal instillation of rats with DEP or
vehicle (saline).
Results
Assessment of pulmonary inflammation
Instillation of DEP was associated with an influx of neu-
trophils and macrophages into bronchoaveolar lavage
fluid (BALF). Black particles were evident within these
cells following DEP instillation (Figure 1a). Instillation of
saline produced no significant alteration in the total cell
number in BALF compared with untreated control ani-
mals. However, instillation of DEP increased the number
of cells in lavage 6 h and 24 h post-exposure (Figure 1b).
Total cell counts were greatest 6 h post-exposure (130 ±
35 × 105/mL versus 17 ± 5 × 105/mL in saline controls,
P < 0.001) and remained elevated at 24 h (49 ± 10 × 105
cells/mL versus 8.3 ± 1.8 × 105 cells/mL in saline-treated
controls). The increase in the total cell count 6 h after
DEP instillation was predominately due to increases in
neutrophil number (Figure 1c). There were no differences
in the number of macrophages in BALF between the
treatment groups (Figure 1d) and, in all groups, eosino-
phil and lymphocyte numbers were below the threshold
for detection. This pattern of cell differentials was identi-
cal when expressed as a percentage of total cell number
(data not shown).
Protein concentration in the BALF was measured as a
surrogate of lung permeability [23]. After saline-instillation,
total protein concentration was similar to baseline levels at
all time-points (Figure 1e). In contrast, total protein
increased 2- to 3-fold 6 h after DEP instillation (P < 0.001,
n = 6-8; Figure 1e), with levels returning to baseline by
24 h. Measurement of the cytokine interleukin-6 (IL-6)
showed a similar pattern with levels increasing above base-
line (0.30 ± 0.07 ng/ml) 6 h after DEP instillation (10.5 ±
1.8 ng/ml; P < 0.001) and returning to baseline within 24 h
(Figure 1f). Levels of tumour necrosis factor alpha (TNFa)
and C-reactive protein (CRP) were also measured in the
BALF, but both were below the limits of detection (< 16
pg/ml for TNFa and < 39 pg/ml for CRP).
Assessment of inflammatory response in blood
Red blood cell and platelet counts were not different
across treatment groups (Table 1). There was a signifi-
cant increase in numbers of white blood cells at 6 h after
instillation (P < 0.05), that decreased to levels that were
not significantly different to those of the saline-treated
group at 24 h (Table 1). Baseline plasma IL-6 and TNFa
levels were 53.5 ± 11.5 pg/ml and 5.8 ± 1.5 pg/ml, respec-
tively (Figure 2a &2b) and there was no significant
change from baseline at 6 h after DEP or saline instilla-
tion. At 24 h after instillation, DEP induced significantly
higher levels of both IL-6 (P < 0.05; Figure 2a) and TNFa
(P < 0.01; Figure 2b) in comparison to the saline instilled
group. Although intratracheal instillation of DEP elevated
baseline levels of circulating CRP at both time points
(Figure 2c), no statistical differences were observed
between the saline and DEP groups.
In vivo vascular function
Baseline systolic blood pressure was significantly higher
in DEP-, than in saline-, treated rats 6 h after exposure
(P < 0.05; Table 2). Diastolic and mean arterial pressure
showed the same trend, but this failed to reach statistical
significance. Baseline heart rate and blood flow were not
different between treatment groups (Table 2).
Intra-arterial injections of acetylcholine (ACh) into the
hind-limb vascular bed increased femoral vascular conduc-
tance (FVC; Figure 3a &3b) without affecting mean arterial
blood pressure. Neither saline nor DEP administration
altered arteriolar dilations in response to ACh at either 6 h
(Figure 3a) or 24 h (Figure 3b) after instillation. Intra-
arterial administration of sodium nitroprusside (SNP) was
associated with a tendency for a transient reduction in
mean arterial blood pressure (6-12 mmHg in both saline-
and DEP- exposed rats) but this change in blood pressure
was not statistically significant in any group (P > 0.10 for
all). SNP (0.9 μg) produced approximately a 2-fold
increase in vascular conductance above baseline in the
non-instilled control animals and in saline-instilled ani-
mals at 6 h or 24 h after instillation (Figure 3c & Figure
3d). At both time points DEP significantly suppressed this
increase in conductance evoked by SNP (Figure 3c &3d).
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Figure 1 Instillation of diesel exhaust particles (DEP) causes transient pulmonary inflammation. (a) Representative photomicrograph of a
cytocentrifuge slide prepared from bronchoalveolar lavage fluid (BALF) collected from a DEP-instilled animal 6 h after instillation. Neutrophils
(open arrow) and alveolar macrophages (black arrow) containing particulate (purple arrow) are apparent. Diff-Quick™ staining, ×400
magnification. BALF was analysed for (b) total cell count, (c) neutrophils, (d) alveolar macrophages, (e) total protein (bicinchonic acid assay) and
(f) interleukin-6 (IL-6). Non-instilled (open columns), saline-instilled (solid columns) and DEP-instilled (hatched columns) animals 6 and 24 h after
instillation. Results are expressed as mean ± SEM (n = 4-8; data for non-instilled groups were pooled, n = 11) ***P < 0.001 DEP versus saline;
two-way ANOVA followed by Bonferroni post-hoc test.
Table 1 Blood cell differentials 6 or 24 h after instillation of diesel exhaust particulate (DEP) or saline
Treatment group
6 h 24 h
Non-instilled Saline DEP Saline DEP
RBC
(×103/pl)
5.9 ± 0.3 5.4 ± 0.3 5.6 ± 0.2 5.6 ± 0.3 5.3 ± 0.3
WBC
(×103/μl)
4.6 ± 0.5 5.8 ± 0.4 8.6 ± 0.3* 4.6 ± 1.0 5.7 ± 1.4
platelets
(×103/μl)
358 ± 93 415 ± 106 447 ± 49 525 ± 177 618 ± 164
Abbreviations: DEP, diesel exhaust particles; RBC = red blood cells; WBC, white blood cells.
Results are mean ± SEM (n = 5). Not significant (P > 0.05) unless otherwise stated. *P < 0.05, saline vs DEP, Bonferroni post-hoc test, following two-way ANOVA
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Ex vivo vascular function
Responses to vasodilator drugs were assessed ex vivo in
thoracic aortas from rats, 6 or 24 h after instillation
(Figure 4, Table 3). DEP-instillation had no effect on the
sensitivity of the contractile responses to phenylephrine
in either the 6 h (P = 0.31) or 24 h groups (P = 0.82;
Figure 4a), although there was a significantly greater
maximum contraction to phenylephrine in the 6 h DEP
group (P = 0.045; Table 3). Importantly, DEP had no
influence on vasodilator responses to ACh (P = 0.68 for
6 h, P = 0.89 for 24 h; Figure 4b) or SNP (P = 0.79 for
6 h, P = 0.22 for 24 h; Figure 4c) at either time point.
In an additional group of animals sacrificed 2 h after
instillation, responses to ACh and SNP were identical in
saline- and DEP-treated animals at this earlier time
point (n = 6; data not shown). There was no significant
difference between the concentration-response curves to
isoprenaline, as a whole, in the aortas from saline- and
DEP-treated animals (two-way ANOVA; P > 0.06; Figure
4d), although a small, but significant, difference in IC50
values was observed at 6 h (unpaired t-test; P = 0.013;
Table 3).
To assess the possibility of the effects of DEP being
apparent in blood vessels other than the thoracic aorta,
vascular responses were also assessed in another conduit
artery (femoral) and in a resistance artery (3rd order
mesenteric). Responses to phenylephrine were similar in
femoral and mesenteric arteries from DEP- and saline-
treated animals (P > 0.05; Table 3). There were no differ-
ences in the responses to ACh between saline-instilled or
DEP-instilled animals in either femoral (P > 0.36; Figure
4e) or mesenteric arteries (P > 0.08; Figure 4f) at either
time point. Responses to other vasodilators were similar
in these vessels from DEP and saline treated animals,
with the exception that there was a significantly greater
sensitivity to SNP in mesenteric arteries (P = 0.002; two-
way ANOVA; IC50, P = 0.004) from DEP-treated rats
(Table 3).
Discussion
Using a rat model, we have shown that acute pulmonary
exposure to DEP induces both pulmonary and systemic
inflammation, yet does not cause vascular endothelial
dysfunction measured either in vivo or ex vivo.
In recent studies, we have shown both short- and long-
term vascular and endothelial impairment in humans after
exposure to diesel exhaust [8,9,11]. These effects appear to
be mediated by the particulate components of the diesel
exhaust [7,10]. To permit further investigation into the
mechanism of DEP-induced vascular dysfunction, we
exposed rats specifically to the particulate components of
diesel exhaust via pulmonary instillation. Intratracheal
instillation of particle suspensions has been shown to be a
reliable way of producing excellent dispersion of particles
throughout the lobes of rodent lungs and across the sur-
face of the alveoli, leading to pulmonary effects that are
directly comparable to that of inhalation studies [24-27].
Thus we used this method to test the hypothesis that DEP
impairs endothelial function through the generation of
pulmonary and systemic inflammation.
Inflammation has been implicated in many of the
actions of DEP and other particles, including actions on
the cardiovascular system [19]. It has been suggested that
the pulmonary inflammation induced by particles leads to
raised levels of inflammatory mediators within the circula-
tion, that have detrimental actions on the vasculature.
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Figure 2 Instillation of diesel exhaust particles (DEP) causes
systemic inflammation. Plasma cytokines (a) Interleukin-6 (IL-6) (b)
Tumour necrosis factor alpha (TNFa) & (c) C-reactive protein (CRP)
were detected by ELISA. Non-instilled (open columns), saline-
instilled (solid column) or DEP-instilled (0.5 mg; hatched columns)
animals 6 and 24 h after instillation. Results are expressed as mean
± SEM (n = 4-6). , *P < 0.05, **P < 0.01 DEP versus saline; two-way
ANOVA followed by Bonferroni post-hoc test.
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Table 2 Baseline heart rate, arterial pressure and hind-limb blood flow 6 and 24 h after instillation of diesel exhaust
particulate (DEP) or saline (assessed before vasodilator administration)
Treatment group
6 h 24 h
Non-instilled Saline DEP Saline DEP
HR
(bpm)
354 ± 6 352 ± 7 372 ± 11 335 ± 6 353 ± 7
SBP
(mmHg)
103.9 ± 5.7 105.1 ± 5.1 130.7 ± 13.4* 101.3 ± 2.4 116.9 ± 5.9
DBP
(mmHg)
88.9 ± 6.5 98.7 ± 5.0 122.5 ± 12.8 85.3 ± 2.2 101.8 ± 7.1
MABP
(mmHg)
91.4 ± 7.4 100.9 ± 5.0 125.3 ± 13.0 91.2 ± 1.8 106.8 ± 6.5
HBF
(ml/min)
2.3 ± 0.3 2.4 ± 0.4 2.7 ± 0.2 2.0 ± 0.3 2.6 ± 0.3
DEP, Diesel Exhaust Particles; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; MABP, mean arterial blood pressure; HBF, hind-limb blood
flow.
Results are mean ± SEM (n = 5-8). Not significant (P > 0.05) unless otherwise stated. *P < 0.05, saline vs DEP, Bonferroni post-hoc test, following two-way ANOVA
Figure 3 Instillation of diesel exhaust particles (DEP) does not affect endothelium-dependent relaxation, but impairs vasodilator
response to sodium nitroprusside, in vivo. Percent change in femoral vascular conductance (FVC) from baseline in response to intra-arterial
acetylcholine (ACh; 0.07 & 0.7 μg) and sodium nitroprusside (SNP; 0.09 & 0.9 μg) 6 h (a &c) and 24 h (b &d) after instillation. Responses were
obtained in non-instilled rats (open column), saline-instilled rats (solid column) or DEP-instilled rats (0.5 mg; hatched column). Results are
expressed as mean ± SEM (n = 4-6). *P < 0.05, **P < 0.01 DEP versus saline; two-way ANOVA followed by Bonferroni post-hoc test.
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Figure 4 Instillation of diesel exhaust particles (DEP) has no effect on vascular responses ex vivo. (a) Contraction to phenylephrine (PE),
and relaxation to (b) acetylcholine (ACh), (c) sodium nitroprusside (SNP) and (d) isoprenaline (ISP) in the thoracic aorta. Responses to ACh in (e)
femoral artery and (f) 3rd order mesenteric arteries. Data from saline-instilled animals (open symbols) and DEP-instilled animals (closed symbols)
sacrificed at 6 h (circles, solid line) or 24 h (triangles, dashed line) after instillation. Results are expressed as mean ± SEM (n = 6-10). No significant
differences were found between saline or DEP instilled animals at either time points for all vessels (two-way ANOVA).
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Table 3 Ex vivo contractile and relaxant responses in arterial rings isolated 6 and 24 h after instillation of rats with diesel exhaust particles (DEP) or saline
phenylephrine acetylcholine sodium nitroprusside isoprenaline
logEC50 Max
(% response to KCl)
logIC50 Imax
(% preconstriction)
logIC50 Imax
(% preconstriction)
logIC50 Imax
(% preconstriction)
Aorta
6 h
saline -7.24 ± 0.14 67.1 ± 8.1 -7.88 ± 0.20 94.9 ± 1.3 -8.67 ± 0.13 96.7 ± 1.0 -7.52 ± 0.15 90.0 ± 1.8
DEP -7.03 ± 0.07 88.6 ± 5.1* -7.75 ± 0.11 96.1 ± 1.4 -8.70 ± 0.11 87.9 ± 1.0 -8.07 ± 0.10* 93.1 ± 2.2
24 h
saline -7.29 ± 0.13 120.8 ± 14.5 -7.52 ± 0.10 99.3 ± 0.5 -8.43 ± 0.13 99.3 ± 0.6 -7.62 ± 0.16 88.0 ± 5.8
DEP -7.38 ± 0.11 115.3 ± 13.0 -7.67 ± 0.17 96.2 ± 1.5 -8.60 ± 0.10 98.9 ± 0.4 -7.62 ± 0.26 87.8 ± 6.4
Femoral Artery
6 h
saline -5.59 ± 0.08 115.1 ± 24.2 -6.69 ± 0.11 68.9 ± 4.9 -7.80 ± 0.15 94.1 ± 2.9 -6.39 ± 0.29 67.3 ± 7.1
DEP -5.53 ± 0.06 91.8 ± 4.0 -6.81 ± 0.14 77.2 ± 5.6 -7.81 ± 0.18 95.1 ± 1.9 -6.51 ± 0.27 77.4 ± 3.9
24 h
saline -5.46 ± 0.24 136.0 ± 32.4 -6.79 ± 0.18 61.2 ± 4.7 -7.64 ± 0.18 92.7 ± 2.7 -7.03 ± 0.14 41.8 ± 4.8
DEP -5.46 ± 0.09 124.2 ± 11.4 -6.86 ± 0.14 68.3 ± 6.3 -7.81 ± 0.18 92.5 ± 2.2 -7.07 ± 0.23 58.7 ± 6.5
Mesenteric Artery
6 h
saline -6.02 ± 0.15 96.1 ± 3.6 -7.29 ± 0.27 76.4 ± 7.8 -7.82 ± 0.15 98.1 ± 2.2 -8.19 ± 0.17 101.3 ± 0.7
DEP -5.76 ± 0.19 99.3 ± 3.9 -7.51 ± 0.11 88.4 ± 3.6 -8.36 ± 0.05** 98.3 ± 1.4 -8.80 ± 0.24 99.6 ± 1.2
24 h
saline -6.19 ± 0.11 103.6 ± 5.9 -7.65 ± 0.23 82.0 ± 5.0 -8.40 ± 0.15 99.1 ± 1.1 -8.74 ± 0.16 102.4 ± 0.9
DEP -6.07 ± 0.11 132.9 ± 13.1 -7.58 ± 0.17 80.6 ± 5.8 -8.28 ± 0.19 99.3 ± 3.4 -8.32 ± 0.21 102.5 ± 0.4
Results are mean ± SEM (n = 5-10), obtained by non-linear regression
*P < 0.05, **P < 0.01, control vs DEP, unpaired t-test.
EC50 - concentration producing 50% of maximum contraction
Emax - maximum contraction
IC50 - concentration producing 50% of maximum vasodilatation
Imax - maximum vasodilatation
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Pulmonary exposure to DEP produces a clear lung inflam-
mation that peaks ~6-12 h after instillation and persists
for over 24 h [18,20]. While the pulmonary actions of DEP
are relatively consistent, measures of particle-induced sys-
temic inflammatory response are notoriously variable
[28-30]. In the present study we showed that DEP induced
pulmonary inflammation 6 h after exposure. This was
characterised by marked neutrophil infiltration, raised
levels of the inflammatory mediator IL-6 and an increase
in alveolar permeability, characterised by increased levels
of protein in BALF. Pulmonary inflammation was largely
resolved 24 h after exposure. While there was no indica-
tion of systemic inflammation at 6 h after DEP instillation,
the levels of two inflammatory mediators, IL-6 and TNFa
were increased in the plasma by 24 h after exposure. The
time course of these responses could suggest that these
factors originate from the prior inflammatory response in
the lung. Previous studies in animals [31,32] and man
[33,34] report raised levels of CRP in the blood following
exposure to urban particulates or episodes of high air pol-
lution, yet we did not find any changes in this mediator
after DEP instillation. Differences in the type and composi-
tion of the particulate or co-pollutant may explain these
discrepancies (see below). Regardless, these results high-
light the need to measure multiple markers of inflamma-
tion to ensure that the systemic consequences of particle
instillation are not overlooked.
In the present study we found that DEP instillation had
no effect on endothelium-dependent vasodilatation,
either in vivo or ex vivo. Previous studies have reported
that DEP exposure by either inhalation or instillation is
associated with endothelial dysfunction [35-37]. Similarly,
exposure of rodents to urban PM has been reported to
attenuate vascular function [38-41]. However, several stu-
dies have found that pulmonary exposure to DEP or
urban PM, by both inhalation and instillation, had no
effect on responses to vasodilators despite the high doses
of particulate employed [42-44]. Similarly negative find-
ings may be under-represented due to the tendency not
to report negative data. The reason for these discrepan-
cies is likely to be multifactorial, being influenced by
dose and duration employed, type of particle, differences
in animal species and blood vessel used as well as how
the measurements are made.
The dose of particle used in the current study is high:
approximately 30-fold higher than the comparable alveolar
deposition from a 24 h inhalation of 100 μg/m3 in man
(MPPD model, adjusted rat lung surface area) [45]. Thus,
we do not believe that we have failed to observe an effect
due to use of an inappropriately low dose. One of the
notable differences between the present instillation study
and real world exposures is that here we administer the
particulate alone. Gases and semi-volatile compounds in
whole diesel exhaust have the potential to produce
vascular effects, although data from gaseous constituents
alone is highly inconsistent and often only seen at high
concentrations of these pollutants [44,46]. Furthermore, in
our clinical exposures, the vascular action of diesel exhaust
was abolished if particles were filtered from the emissions
[7,10]. A second consideration is the composition of the
particulate itself. The physiochemical properties of DEP
vary markedly depending on the fuel used and the engine
type and running conditions. In the present study we used
widely available ‘standard’ DEP from the National Institute
of Standards and Technology (NIST), a frequently used
source of DEP that acts as a benchmark for comparisons
of the biological effects of DEP between studies. Interest-
ingly isolated studies have shown that ‘clean’ carbon parti-
cles have the capacity to impair vascular function [47] or
promote atherosclerosis [48]. Similarly, even nanoparticles
believed to be inert (e.g. titanium dioxide nanoparticles)
have occasional been reported to have vascular effects
[41,49]. However, generally, the cardiovascular actions of
these particles are small in comparison to that of urban
PM or DEP [50,51], and are not evident in controlled
exposures in humans [10]. Therefore, the quantities and
properties of surface chemicals within DEP (e.g. organic
constituents, transition metals) could account from a
degree of variability between the vascular effects of differ-
ent sources of DEP. Finally, species differences should also
be considered, not just between human and rodent mod-
els, but also between different animal species, source of
animals (e.g. inbred vs outbred animals) and the use of dif-
ferent animal models of disease.
Experiments in the present study were specifically
designed to maximise the chances of detecting alterations
in vascular function by making measurements in vivo
where the neurohumoural systems are intact, as well as
ex vivo both in conduit and resistance arteries. In the
anaesthetised rat, both the endothelium-dependent vaso-
dilator ACh and the endothelium-independent vasodila-
tor SNP induced an increase in hind-limb blood flow.
Both agents were delivered locally via the femoral artery
to avoid reduction of systemic blood pressure and the
associated reflex vasoconstriction [52], although there
was a tendency for SNP to induce a small transient
reduction in mean arterial blood pressure, suggesting a
small degree of systemic activity. In animals that had
received DEP 6 h prior to assessment of vascular func-
tion, responses to ACh in the hind-limb resistance bed
were not different from those achieved in saline-instilled
animals. This contrasts with our clinical studies in the
forearm resistance bed, in which endothelium-dependent
relaxation was impaired after diesel exhaust exposure
[8,9,11]. The in vivo measurements were supported by a
lack of effect of DEP on vascular function ex vivo. This
lack of effect of DEP disproves our original hypothesis
that pulmonary exposure to this particulate will impair
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vasodilator responses. However, the results do provide
important insights into the mechanism of the cardiovas-
cular effects of instilled DEP. Importantly, endothelial
function was preserved at times when there was signifi-
cant pulmonary (6 h) and systemic (24 h) inflammation,
suggesting that inflammation alone is unlikely to account
for the cardiovascular actions of inhaled particulates.
Indeed, other studies have demonstrated endothelial dys-
function without inflammation [53,54], supporting the
notion that the two phenomena are independent.
Endothelium-independent relaxation (SNP, isoprena-
line) ex vivo was also unaffected by DEP instillation, sug-
gesting that the ability of smooth muscle to relax is not
impaired following exposure to DEP in vivo. However, in
contrast, the increase in hind-limb blood flow induced by
SNP in vivo was impaired both 6 and 24 h after adminis-
tration of DEP. The change in blood flow in vivo depends
on the balance between vasorelaxation and vasoconstric-
tion after drug administration. The fact that the increase
in hind-limb blood flow induced by SNP is reduced in
animals that received DEP could, therefore, be the result
of reduced vasorelaxation. A change in muscle sensitivity
is unlikely as responses to ACh were not affected and we
could not detect any change ex vivo, but we cannot rule
out a change in bioactivity as a result of, say, increased
oxidative stress [12,55] localised to the site of NO release
from SNP. The reduced response to SNP could also be
explained by increased vasoconstriction due to other
counteracting constrictor influences such as endothelin
or angiotensin II, or to increased sympathetic nerve activ-
ity. Alterations in these pathways could account for the
raised blood pressure following PM exposure [56-58], as
evidenced by the increased baseline systolic blood pres-
sure in DEP-instilled rats in the current study. Addition-
ally, the latter hypothesis is attractive given the evidence
in the literature for increased autonomic activity and bar-
oreceptor sensitivity in response to PM [17,59-62]. How-
ever, at present we can only speculate on the mechanism
involved. Further experimentation is required to fully
investigate the mechanisms involved.
Conclusions
Using a series of in vivo and ex vivo experiments we
have shown that instillation of diesel exhaust particulate
in rats causes both pulmonary and systemic inflamma-
tion, but this is not associated with impaired endothelial
function. However, DEP administration produced speci-
fic impairments in the response to SNP in vivo that
require further investigation.
Materials and methods
Animals
Adult male Wistar rats (200-250 g; Charles River, Mar-
gate, UK; at least 4 animals per treatment group) were
housed under controlled environmental conditions (21 ±
2°C; 12 h light/dark cycle) with access to tap water and
standard laboratory rat chow ad-libitum. All rats were
allowed to acclimatize to the environment for at least
one week before experimental procedures were initiated.
All experiments were performed according to the Ani-
mals (Scientific Procedures) Act 1986 (U.K. Home
Office).
Pulmonary instillation of DEP
DEP (SRM-2975; National Institute of Standards and
Technology, Gaithersburg, USA) was suspended in
0.9% sterile saline at a stock concentration of 1 mg/mL
and sonicated for 5 min (70% power; 5 Hz) in an ice
bath using a probe-type sonicator (US70; Philip Harris
Scientific, Lichfield, U.K.) to minimise particulate
aggregation.
DEP was administered by intra-tracheal instillation as
previously described [59]. Briefly, rats were anesthetised,
using 5% isoflurane inhalation (Meriol, Essex, UK), and
positioned head-upwards on a board inclined at a 45°
angle. The vocal chords were visualised by passing a
pediatric laryngoscope with a plastic cannula into the
trachea. Particles (0.5 mg/rat) or vehicle (saline) were
then instilled as a 0.5 mL bolus. The dose used is com-
parable to previous studies [20,30,63,64] and preliminary
experiments showed that this dose of DEP induces sys-
temic effects without acute toxicity [59]. An additional
group of non-instilled rats was used to confirm that sal-
ine instillation itself did not have significant pulmonary
and systemic actions.
Collection and analysis of bronchoalveolar lavage fluid
(BALF)
Immediately after sacrifice BALF was collected for
assessment of the inflammatory responses in the lungs
of instilled animals, as described [59]. Briefly, the tra-
chea was exposed and cannulated (0.3 mm O.D., stain-
less steel) allowing the lungs to be lavaged with 8 mL of
sterile saline. The lungs were gently aspirated and the
process repeated a further three times (24 ml total).
BALF was centrifuged at 1800 g for 5 min. The superna-
tant from the first lavage was separated into 1 mL ali-
quots and stored at -80°C until required for biochemical
determination. Total protein levels in BALF were deter-
mined using a standard bicinchoninic acid kit (Thermo
Scientific Pierce, Northumberland, UK) to assess
alveolo-capillary permeability as an indicator of lung
inflammation. Additionally BALF was analysed for
changes in the inflammatory mediators, C-reactive pro-
tein (CRP), tumor necrosis factor alpha (TNFa) and
interleukin-6 (IL-6) by enzyme-linked immunosorbent
assay (ELISA; DuoSet kits, R&D Systems, Abingdon,
UK) according to the manufacturer’s instructions.
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The cell pellets from all lavages were resuspended in 1
mL of physiological saline and combined. Total cell num-
ber was measured using an automatic cell counter (Sar-
torius Steadman, Chemometec, Nuclecounter®,
Gydevang, Denmark (941-0002)). For cell differentials,
cytospin preparations were performed by centrifuging
(300 rpm for 3 min; Shandon cytospin 3 centrifuge)
10,000 cells in 300 μL phosphate buffered saline contain-
ing 0.1% bovine serum albumin onto Superfrost Plus
glass slides (VWR International, Lutterworth, UK).
Cytospins were air-dried, fixed with 100% methanol (1
min) and then stained using Diff-Quik™ (Raymond A.
Lamb, London, UK). The differential cell count was per-
formed from an average of 300 cells per slide using a
hemocytometer (Sigma-Aldrich, Dorset, UK) under 400
× magnification. BALF was collected following comple-
tion of the vascular measurements under anaesthesia (see
below). Data obtained for all parameters were similar to
those collected previously from animals that had not
undergone this surgical intervention (data not shown).
Hematological assays
Blood was taken from the carotid artery immediately
before sacrifice into ice-cooled tubes containing heparin
(final concentration 100 U/mL). The mean values of dif-
ferent hematological parameters; white blood cells, red
blood cells and platelets; were measured with the Coul-
ter®Ac.T series analyzer (Coulter Corporation, Miami,
USA). The remaining blood was centrifuged at 1500 g
for 5 min to isolate plasma, which was used for assess-
ment of systemic inflammation by measuring CRP
(DuoSet kit), TNFa (Quantikine kit) and IL-6 (Quanti-
kine kit) by ELISA (R & D Systems) according to the
manufacturer’s instructions. Blood was collected follow-
ing completion of the vascular measurements under
anaesthesia (see below). Data obtained for all parameters
were similar to those from animals that had not under-
gone this surgical intervention (data not shown).
In vivo vascular function in the hind-limb
Vascular function was studied 6 or 24 h after instillation
to assess changes in vascular response over the course
of the DEP-induced inflammatory response. Rats were
anesthetized with isoflurane (5% for induction and 2-
2.5% for maintenance) and body temperature was main-
tained at 37°C with a thermostatically-controlled under-
blanket (Homeothermic Blanket Control Unit, Harvard
Apparatus, UK). The right carotid artery was exposed by
blunt dissection, cannulated with a heparinised saline-
filled (final concentration 100 U/mL) polyethylene tube,
and connected to a fluid filled pressure transducer
(Powerlab/4SP, ADInstruments, UK) for continuous
monitoring of arterial blood pressure (systolic, diastolic
and mean) and heart rate.
Vascular responses to drugs administrated intra-arterially
were monitored in the left hind-limb based on the method
of Jackson et al. (2010) [65]. For drug delivery the right
femoral artery was exposed and a polyethylene cannula
(0.61 mm o.d., 0.28 mm i.d., Portex, Jencons Scientific Ltd,
Bedfordshire, UK) was inserted, gently advanced until its
tip reached the bifurcation of the abdominal aorta and
secured with silk ligatures at the point of insertion. For
flow measurements, a midline incision was performed in
the abdominal wall and the left iliac artery just distal to the
aortic bifurcation was carefully isolated from surrounding
tissue. A flow probe (type 0.7 V; Transonic Systems, Nor-
folk) was positioned around the artery and covered with
surgical lubricating jelly (Fougera, Atlanta). Hind-limb
blood flow (mm/min) was monitored continuously
throughout the study via a Transonic TS420 flowmeter
(Transonic Systems) connected to a MacLab/4e (AD
instruments, AD Instruments, Sussex, UK) data acquisition
system. Upon attaining a steady blood flow, boluses of the
endothelium-dependent vasodilator ACh (0.07 and 0.7 μg)
were delivered in a volume of 10 μL via a microsyringe (25
μL, Hamilton Bonaduz AG, Bonaduz, Switzerland)
attached to the cannula leading to the abdominal aorta.
Injection of 10 μL saline itself had no effect on hind-limb
blood flow. ACh and saline were given in a randomised
order, followed by increasing doses of the endothelium-
independent, nitric oxide donor SNP (0.09 and 0.9 μg).
Preliminary studies in our laboratory suggested that these
doses of ACh and SNP are sufficient to increase blood flow
in the hind-limb while avoiding spill-over into the systemic
circulation and influencing mean blood pressure, as com-
pared with identical doses of acetylcholine and SNP given
intravenously (data not shown). Blood flow was allowed to
return to baseline before administering the next drug.
Femoral vascular conductance (FVC) was calculated as
femoral blood flow/mean arterial pressure.
Ex vivo vascular function using myography
The thoracic aorta, a region of uninjured femoral artery
and 3rd order mesenteric resistance arteries were isolated
from animals 6 or 24 h after instillation, and cleaned of
connective tissue. Segments of aorta (~5 mm length),
femoral and mesenteric arteries (both 1-2 mm length)
were mounted in a multi-myograph system (610 M; Dan-
ish Myo Technology, Aarhus, Denmark) [12], using 40 μm
diameter wire for smaller vessels. Vessels were submerged
in Krebs buffer (composition in mM: 118.4 NaCl, 25
NaHCO3, 11 glucose, 4.7 KCl, 1.2 MgSO4, 1.2 KH2PO4,
0.027 ethylenediaminetetraacetic acid, 2.5 CaCl2) bubbled
with 5% CO2/95% O2 at 37°C before a baseline tension of
14.7 mN (aorta), 8 mN (femoral) or 4 mN (mesenteric)
was gradually applied over 10 min and vessels were
allowed to equilibrate for a further 30 min. Preliminary
experiments showed that these pretension levels produced
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optimal contraction and dilatation responses. Data from
force transducers were processed by a MacLab/4e analo-
gue-digital converter displayed through Chart™ software
(AD Instruments, Sussex, UK).
Vessel viability was confirmed by a contractile response
on addition of 80 mM KCl, repeated 3 times (aorta) or
serial addition of high K+Krebs (Krebs with substitution of
4.7 mM NaCl and 118.4 mM KCl) together with 10 μM
noradrenaline (femoral and mesenteric arteries). Concen-
tration-response curves to phenylephrine (PE; 1 nM - 10
μM) were obtained and a concentration that produced
80% maximum contraction (EC80; 0.1-1 μM) was chosen
for each individual arterial segment. Following sub-maxi-
mal contraction with the appropriate concentration of PE,
cumulative concentration-response curves were obtained
for acetylcholine (1 nM - 10 μM), SNP (0.1 nM - 3 μM)
and a nitric oxide-independent vasodilator (isoprenaline;
0.1 nM - 10 μM). At least 30 min washout was allowed
before application of subsequent drugs.
Blood vessels were isolated from taken from regions
undamaged by the surgical procedure, from animals that
had undergone vascular measurements in vivo. To
obtain sufficient n-numbers for all vessel types, blood
vessels were also obtained from additional animals that
had not undergone the surgical procedure. Responses
were identical in both groups of animals, therefore, the
data-sets were combined.
Drugs and reagents
Krebs salts were obtained from VWR International (Lut-
terworth, UK). All other drugs were obtained from Sigma
Ltd. (Poole, UK). All drugs were dissolved and diluted in
saline or Krebs buffer. Preliminary experiments confirmed
that, in all cases, addition of vehicle alone had no effect on
any of the parameters measured.
Statistical analysis
Data are expressed as the mean ± standard error of the
mean (SEM). Differences in FVC response were expressed
as a change from baseline. Myography responses are
expressed as percentage of the pre-contraction to EC80 PE,
where positive values represent vasodilatation and 100%
vasodilatation represents a complete abolition of PE-
induced tone. Statistical comparisons were performed by
one-way analysis of variance (ANOVA) followed by
Tukey’s post-hoc tests (pulmonary and systemic inflam-
mation), two-way ANOVA using the Bonferroni post-hoc
test (blood flow and blood pressure, ex vivo concentration
response curves) or unpaired Student’s t-test (ex vivo EC50
and Emax values), unless otherwise stated. Statistical ana-
lyses were performed using GraphPad Prism software
(V5.0; GraphPad Software Inc, USA). P < 0.05 was consid-
ered to be statistically significant.
Abbreviations
ACh: acetylcholine; ANOVA: analysis of variance; BALF: bronchoalveolar
lavage fluid; CRP: C-reactive protein; DEP: diesel exhaust particulate; FVC:
femoral vascular conductance; HBF: hind-limb blood flow; IL-6: Interleukin 6;
NIST: National Institute of Standards and Technology; PE: phenylephrine; PM:
particulate matter; SEM: standard error of the mean; SNP: sodium
nitroprusside; TNFα: tumour necrosis factor alpha.
Acknowledgements
This work was funded by a British Heart Foundation Programme Grant (RG/
05/003) and a 4-year British heart Foundation PhD Studentship (FS/07/063)
with additional financial support for equipment from a University of
Edinburgh Development Trust Small Project Grant. We also acknowledge the
support of the British Heart Foundation Centre of Research Excellence
(CoRE) award.
Funding
British Heart Foundation Programme Grant (RG/05/003), 4-year British Heart
Foundation PhD Studentship (FS/07/063) and a University of Edinburgh
Development Trust Small Project Grant. The authors have no competing
interests to declare.
Author details
1Centre of Cardiovascular Science, University of Edinburgh, Edinburgh,
Scotland, UK. 2Centre for Inflammation Research, University of Edinburgh,
Edinburgh, Scotland, UK. 3BHF/University Centre for Cardiovascular Science,
University of Edinburgh, The Queen’s Medical Research Institute, 47 Little
France Crescent, Edinburgh EH16 4TJ, UK.
Authors’ contributions
SR carried out the in vivo vascular studies and measures of inflammation,
performed the statistical analysis and drafted the manuscript. GAG
conceived the in vivo study, participated in its design and coordination,
helped to draft the manuscript. RD assisted with the particle instillations and
design of the pulmonary assays. SGM carried out the aortic ex vivo vascular
studies. PWFH participated in the design of the study, the surgical
procedures and helped to draft the manuscript. CAS and DEN helped to
draft the manuscript. MRM carried out the femoral and mesenteric ex vivo
vascular studies and statistical analysis, participated in its design and
coordination and helped to draft the manuscript. All authors read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 22 August 2011 Accepted: 5 April 2012
Published: 5 April 2012
References
1. Bhatnagar A: Environmental cardiology: studying mechanistic links
between pollution and heart disease. Circ Res 2006, 99:692-705.
2. Brook RD, Brook JR, Rajagopalan S: Air pollution: the “Heart” of the
problem. Curr Hypertens Rep 2003, 5:32-39.
3. Dockery DW, Pope CA, Xu X, Spengler JD, Ware JH, Fay ME, Ferris BG Jr,
Speizer FE: An association between air pollution and mortality in six U.S.
cities. N Engl J Med 1993, 329:1753-1759.
4. World Health Organization: World Health Report 2002., [accessed 2007].
5. Oberdorster G: Pulmonary effects of inhaled ultrafine particles. Int Arch
Occup Environ Health 2001, 74:1-8.
6. Baulig A, Sourdeval M, Meyer M, Marano F, Baeza-Squiban A: Biological
effects of atmospheric particles on human bronchial epithelial cells.
Comparison with diesel exhaust particles. Toxicol In Vitro 2003, 17:567-573.
7. Lucking AJ, Lundback M, Barath SL, Mills NL, Sidhu MK, Langrish JP,
Boon NA, Pourazar J, Badimon JJ, Gerlofs-Nijland ME, Cassee FR, Boman C,
Donaldson K, Sandstrom T, Newby DE, Blomberg A: Particle traps prevent
adverse vascular and prothrombotic effects of diesel engine exhaust
inhalation in men. Circulation 2011, 123:1721-1728.
8. Mills NL, Tornqvist H, Robinson SD, Gonzalez M, Darnley K, MacNee W,
Boon NA, Donaldson K, Blomberg A, Sandstrom T, Newby DE: Diesel
exhaust inhalation causes vascular dysfunction and impaired
endogenous fibrinolysis. Circulation 2005, 112:3930-3936.
Robertson et al. Particle and Fibre Toxicology 2012, 9:9
http://www.particleandfibretoxicology.com/content/9/1/9
Page 11 of 13
9. Tornqvist H, Mills NL, Gonzalez M, Miller MR, Robinson SD, Megson IL,
Macnee W, Donaldson K, Soderberg S, Newby DE, Sandstrom T,
Blomberg A: Persistent endothelial dysfunction in humans after diesel
exhaust inhalation. Am J Respir Crit Care Med 2007, 176:395-400.
10. Mills NL, Miller MR, Lucking AJ, Beveridge J, Flint L, Boere AJ, Fokkens PH,
Boon NA, Sandstrom T, Blomberg A, Duffin R, Donaldson K, Hadoke PW,
Cassee FR, Newby DE: Combustion-derived nanoparticulate induces the
adverse vascular effects of diesel exhaust inhalation. Eur Heart J 2011,
32(21):2660-71.
11. Mills NL, Tornqvist H, Gonzalez MC, Vink E, Robinson SD, Soderberg S,
Boon NA, Donaldson K, Sandstrom T, Blomberg A, Newby DE: Ischemic
and thrombotic effects of dilute diesel-exhaust inhalation in men with
coronary heart disease. N Engl J Med 2007, 357:1075-1082.
12. Miller MR, Borthwick SJ, Shaw CA, McLean SG, McClure D, Mills NL, Duffin R,
Donaldson K, Megson IL, Hadoke PW, Newby DE: Direct impairment of
vascular function by diesel exhaust particulate through reduced
bioavailability of endothelium-derived nitric oxide induced by
superoxide free radicals. Environ Health Perspect 2009, 117:611-616.
13. Brown JS, Zeman KL, Bennett WD: Ultrafine particle deposition and
clearance in the healthy and obstructed lung. Am J Respir Crit Care Med
2002, 166:1240-1247.
14. Kreyling WG, Semmler M, Erbe F, Mayer P, Takenaka S, Schulz H,
Oberdorster G, Ziesenis A: Translocation of ultrafine insoluble iridium
particles from lung epithelium to extrapulmonary organs is size
dependent but very low. J Toxicol Environ Health A 2002, 65:1513-1530.
15. Oberdorster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C:
Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol
2004, 16:437-445.
16. Mills NL, Amin N, Robinson SD, Anand A, Davies J, Patel D, de la Fuente JM,
Cassee FR, Boon NA, Macnee W, Millar AM, Donaldson K, Newby DE: Do
inhaled carbon nanoparticles translocate directly into the circulation in
humans? Am J Respir Crit Care Med 2006, 173:426-431.
17. Rhoden CR, Wellenius GA, Ghelfi E, Lawrence J, Gonzalez-Flecha B: PM-
induced cardiac oxidative stress and dysfunction are mediated by
autonomic stimulation. Biochim Biophys Acta 2005, 1725:305-313.
18. Nemmar A, Nemery B, Hoet PH, Vermylen J, Hoylaerts MF: Pulmonary
inflammation and thrombogenicity caused by diesel particles in
hamsters: role of histamine. Am J Respir Crit Care Med 2003,
168:1366-1372.
19. Seaton A, MacNee W, Donaldson K, Godden D: Particulate air pollution
and acute health effects. Lancet 1995, 345:176-178.
20. Madden MC, Richards JH, Dailey LA, Hatch GE, Ghio AJ: Effect of ozone on
diesel exhaust particle toxicity in rat lung. Toxicol Appl Pharmacol 2000,
168:140-148.
21. Mills NL, Robinson SD, Fokkens PHB, Leseman DLAC, Miller MR, Anderson D,
Freney EJ, Heal MR, Donovan RJ, Blomberg A, Sandstrom T, MacNee W,
Boon NA, Donaldson K, Newby DE, Cassee FR: Exposure to concentrated
ambient particles does not affect vascular function in patients with
coronary heart disease. Environ Health Perspect 2008, 116:709-715.
22. Swiston JR, Davidson W, Attridge S, Li GT, Brauer M, van Eeden SF: Wood
smoke exposure induces a pulmonary and systemic inflammatory
response in firefighters. Eur Respir J 2008, 32:129-138.
23. Henderson RF: Use of bronchoalveolar lavage to detect respiratory tract
toxicity of inhaled material. Exp Toxicol Pathol 2005, 57(Suppl 1):155-159.
24. Henderson RF, Driscoll KE, Harkema JR, Lindenschmidt RC, Chang IY,
Maples KR, Barr EB: A comparison of the inflammatory response of the
lung to inhaled versus instilled particles in F344 rats. Fundam Appl
Toxicol 1995, 24:183-197.
25. Miyabara Y, Ichinose T, Takano H, Sagai M: Diesel exhaust inhalation
enhances airway hyperresponsiveness in mice. Int Arch Allergy Immunol
1998, 116:124-131.
26. Miyabara Y, Takano H, Ichinose T, Lim HB, Sagai M: Diesel exhaust
enhances allergic airway inflammation and hyperresponsiveness in mice.
Am J Respir Crit Care Med 1998, 157:1138-1144.
27. Driscoll KE, Costa DL, Hatch G, Henderson R, Oberdorster G, Salem H,
Schlesinger RB: Intratracheal instillation as an exposure technique for the
evaluation of respiratory tract toxicity: uses and limitations. Toxicological
sciences: an official journal of the Society of Toxicology 2000, 55:24-35.
28. Nemmar A, Zia S, Subramaniyan D, Fahim MA, Ali BH: Exacerbation of
thrombotic events by diesel exhaust particle in mouse model of
hypertension. Toxicology 2011, 285:39-45.
29. Gottipolu RR, Wallenborn JG, Karoly ED, Schladweiler MC, Ledbetter AD,
Krantz T, Linak WP, Nyska A, Johnson JA, Thomas R, Richards JE, Jaskot RH,
Kodavanti UP: One-month diesel exhaust inhalation produces
hypertensive gene expression pattern in healthy rats. Environ Health
Perspect 2009, 117:38-46.
30. Yokota S, Seki T, Naito Y, Tachibana S, Hirabayashi N, Nakasaka T, Ohara N,
Kobayashi H: Tracheal instillation of diesel exhaust particles component
causes blood and pulmonary neutrophilia and enhances myocardial
oxidative stress in mice. J Toxicol Sci 2008, 33:609-620.
31. Upadhyay S, Ganguly K, Stoeger T, Semmler-Bhenke M, Takenaka S,
Kreyling WG, Pitz M, Reitmeir P, Peters A, Eickelberg O, Wichmann HE,
Schulz H: Cardiovascular and inflammatory effects of intratracheally
instilled ambient dust from Augsburg, Germany, in spontaneously
hypertensive rats (SHRs). Part Fibre Toxicol 2010, 7:27.
32. Zhao J, Xie Y, Qian X, Jiang R, Song W: Acute effects of fine particles on
cardiovascular system: differences between the spontaneously
hypertensive rats and wistar kyoto rats. Toxicol Lett 2010, 193:50-60.
33. Peters A, Frohlich M, Doring A, Immervoll T, Wichmann HE, Hutchinson WL,
Pepys MB, Koenig W: Particulate air pollution is associated with an acute
phase response in men; results from the MONICA-Augsburg Study. Eur
Heart J 2001, 22:1198-1204.
34. Sandhu RS, Petroni DH, George WJ: Ambient particulate matter, C-reactive
protein, and coronary artery disease. Inhal Toxicol 2005, 17:409-413.
35. Cherng TW, Campen MJ, Knuckles TL, Gonzalez Bosc LV, Kanagy NL:
Impairment of coronary endothelial cell ETB receptor function following
short-term inhalation exposure to whole diesel emissions. Am J Physiol
Regul Integr Comp Physiol 2009, 297(3):R640-7.
36. Knuckles TL, Lund AK, Lucas SN, Campen MJ: Diesel exhaust exposure
enhances venoconstriction via uncoupling of eNOS. Toxicol Appl
Pharmacol 2008, 230:346-351.
37. Kodavanti UP, Thomas R, Ledbetter AD, Schladweiler MC, Shannahan JH,
Wallenborn JG, Lund AK, Campen MJ, Butler EO, Gottipolu RR, Nyska A,
Richards JE, Andrews D, Jaskot RH, McKee J, Kotha SR, Patel RB,
Parinandi NL: Vascular and cardiac impairments in rats inhaling ozone
and diesel exhaust particles. Environ Heal Perspect 2011, 119:312-318.
38. Cozzi E, Hazarika S, Stallings HW, Cascio WE, Devlin RB, Lust RM,
Wingard CJ, Van Scott MR: Ultrafine particulate matter exposure
augments ischemia-reperfusion injury in mice. Am J Physiol Heart Circ
Physiol 2006, 291:H894-903.
39. Kido T, Tamagawa E, Bai N, Suda K, Yang HH, Li Y, Chiang G, Yatera K,
Mukae H, Sin DD, Van Eeden SF: Particulate matter induces translocation
of IL-6 from the lung to the systemic circulation. Am J Respir Cell Mol Biol
2011, 44:197-204.
40. Tamagawa E, Bai N, Morimoto K, Gray C, Mui T, Yatera K, Zhang X, Xing L,
Li Y, Laher I, Sin DD, Man SF, van Eeden SF: Particulate matter exposure
induces persistent lung inflammation and endothelial dysfunction. Am J
Physiol Lung Cell Mol Physiol 2008, 295:L79-L85.
41. LeBlanc AJ, Cumpston JL, Chen BT, Frazer D, Castranova V, Nurkiewicz TR:
Nanoparticle inhalation impairs endothelium-dependent vasodilation in
subepicardial arterioles. J Toxicol Environ Health A 2009, 72:1576-1584.
42. Bagate K, Meiring JJ, Gerlofs-Nijland ME, Vincent R, Cassee FR, Borm PJ:
Vascular effects of ambient particulate matter instillation in spontaneous
hypertensive rats. Toxicol Appl Pharmacol 2004, 197:29-39.
43. Gerlofs-Nijland ME, Totlandsdal AI, Kilinc E, Boere AJ, Fokkens PH,
Leseman DL, Sioutas C, Schwarze PE, Spronk HM, Hadoke PW, Miller MR,
Cassee FR: Pulmonary and cardiovascular effects of traffic-related
particulate matter: 4-week exposure of rats to roadside and diesel
engine exhaust particles. Inhal Toxicol 2010, 22:1162-1173.
44. Quan C, Sun Q, Lippmann M, Chen LC: Comparative effects of inhaled
diesel exhaust and ambient fine particles on inflammation,
atherosclerosis, and vascular dysfunction. Inhal Toxicol 2010, 22:738-753.
45. Cassee FR, Muijser H, Duistermaat E, Freijer JJ, Geerse KB, Marijnissen JC,
Arts JH: Particle size-dependent total mass deposition in lungs
determines inhalation toxicity of cadmium chloride aerosols in rats.
Application of a multiple path dosimetry model. Arch Toxicol 2002,
76:277-286.
46. Campen MJ, Lund AK, Knuckles TL, Conklin DJ, Bishop B, Young D,
Seilkop S, Seagrave J, Reed MD, McDonald JD: Inhaled diesel emissions
alter atherosclerotic plaque composition in ApoE(-/-) mice. Toxicol Appl
Pharmacol 2010, 242:310-317.
Robertson et al. Particle and Fibre Toxicology 2012, 9:9
http://www.particleandfibretoxicology.com/content/9/1/9
Page 12 of 13
47. Vesterdal LK, Folkmann JK, Jacobsen NR, Sheykhzade M, Wallin H, Loft S,
Moller P: Pulmonary exposure to carbon black nanoparticles and
vascular effects. Particle and Fibre Toxicology 2010, 7:33.
48. Niwa Y, Hiura Y, Murayama T, Yokode M, Iwai N: Nano-sized carbon black
exposure exacerbates atherosclerosis in LDL-receptor knockout mice.
Circulation journal: official journal of the Japanese Circulation Society 2007,
71:1157-1161.
49. Nurkiewicz TR, Porter DW, Hubbs AF, Cumpston JL, Chen BT, Frazer DG,
Castranova V: Nanoparticle inhalation augments particle-dependent
systemic microvascular dysfunction. Part Fibre Toxicol 2008, 5:1.
50. Courtois A, Andujar P, Ladeiro Y, Baudrimont I, Delannoy E, Leblais V,
Begueret H, Galland MA, Brochard P, Marano F, Marthan R, Muller B:
Impairment of NO-dependent relaxation in intralobar pulmonary
arteries: comparison of urban particulate matter and manufactured
nanoparticles. Environ Health Perspect 2008, 116:1294-1299.
51. Gurgueira SA, Lawrence J, Coull B, Murthy GG, Gonzalez-Flecha B: Rapid
increases in the steady-state concentration of reactive oxygen species in
the lungs and heart after particulate air pollution inhalation. Environ Heal
Perspect 2002, 110:749-755.
52. Dabisch PA, Liles JT, Baber SR, Golwala NH, Murthy SN, Kadowitz PJ:
Analysis of L-NAME-dependent and -resistant responses to acetylcholine
in the rat. Am J Physiol Heart Circ Physiol 2008, 294:H688-H698.
53. Nurkiewicz TR, Porter DW, Barger M, Castranova V, Boegehold MA:
Particulate matter exposure impairs systemic microvascular
endothelium-dependent dilation. Environ Health Perspect 2004,
112:1299-1306.
54. Nurkiewicz TR, Porter DW, Barger M, Millecchia L, Rao KM, Marvar PJ,
Hubbs AF, Castranova V, Boegehold MA: Systemic microvascular
dysfunction and inflammation after pulmonary particulate matter
exposure. Environ Health Perspect 2006, 114:412-419.
55. Sun Q, Yue P, Ying Z, Cardounel AJ, Brook RD, Devlin R, Hwang JS,
Zweier JL, Chen LC, Rajagopalan S: Air pollution exposure potentiates
hypertension through reactive oxygen species-mediated activation of
Rho/ROCK. Arterioscler Thromb Vasc Biol 2008, 28:1760-1766.
56. Nemmar A, Dhanasekaran S, Yasin J, Ba-Omar H, Fahim MA, Kazzam EE,
Ali BH: Evaluation of the direct systemic and cardiopulmonary effects of
diesel particles in spontaneously hypertensive rats. Toxicology 2009,
262:50-56.
57. Chang CC, Hwang JS, Chan CC, Cheng TJ: Interaction effects of ultrafine
carbon black with iron and nickel on heart rate variability in
spontaneously hypertensive rats. Environ Health Perspect 2007,
115:1012-1017.
58. Zhao J, Cao Q, Qian X, Xie Y, et al: Acute effects of fine particle on
cardiovascular system of rats. Wei Sheng Yan Jiu 2007, 36:417-420.
59. McQueen DS, Donaldson K, Bond SM, McNeilly JD, Newman S, Barton NJ,
Duffin R: Bilateral vagotomy or atropine pre-treatment reduces
experimental diesel-soot induced lung inflammation. Toxicol Appl
Pharmacol 2007, 219:62-71.
60. Gold DR, Damokosh AI, Pope CA: Dockery DW, McDonnell WF, Serrano P,
Retama A, Castillejos M: Particulate and ozone pollutant effects on the
respiratory function of children in southwest Mexico City. Epidemiology
1999, 10:8-16.
61. Pope CA, Lovett EG, Larson AC, Raizenne ME, Kanner RE, Schwartz J,
Villegas GM, Gold DR, Dockery DW: Heart rate variability associated with
particulate air pollution. Am Heart J 1999, 138:890-899.
62. Wellenius GA, Saldiva PH, Batalha JR, Krishna Murthy GG, Coull BA,
Verrier RL, Godleski JJ: Electrocardiographic changes during exposure to
residual oil fly ash (ROFA) particles in a rat model of myocardial
infarction. Toxicol Sci 2002, 66:327-335.
63. Murphy SA, BeruBe KA, Pooley FD, Richards RJ: The response of lung
epithelium to well characterised fine particles. Life Sci 1998, 62:1789-1799.
64. Yan YH, Huang CH, Chen WJ, Wu MF, Cheng TJ: Effects of diesel exhaust
particles on left ventricular function in isoproterenol-induced myocardial
injury and healthy rats. Inhal Toxicol 2008, 20:199-203.
65. Jackson DN, Ellis CG, Shoemaker JK: Estrogen modulates the contribution
of neuropeptide Y to baseline hindlimb blood flow control in female
Sprague-Dawley rats. Am J Physiol Regul Integr Comp Physiol 2010, 298:
R1351-R1357.
doi:10.1186/1743-8977-9-9
Cite this article as: Robertson et al.: Diesel exhaust particulate induces
pulmonary and systemic inflammation in rats without impairing
endothelial function ex vivo or in vivo. Particle and Fibre Toxicology 2012
9:9.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Robertson et al. Particle and Fibre Toxicology 2012, 9:9
http://www.particleandfibretoxicology.com/content/9/1/9
Page 13 of 13
